Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility
June 03, 2024 13:24 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., June 03, 2024 (GLOBE NEWSWIRE) -- Inotiv Inc. – Inotiv Inc. (“Inotiv” or the “Company”) (Nasdaq: NOTV), a leading contract research organization dedicated to providing...
Definitive Healthcare Publishes 2023 Sustainability Report
June 03, 2024 13:08 ET
|
Definitive Healthcare Corp.
Definitive Healthcare publishes 2023 Sustainability Report showcasing continued successes related to culture, governance, and the environment
WISe.ART Partners with Sustainable Fashion Innovation Society on Upcoming Phygital Sustainability Expo
June 03, 2024 13:03 ET
|
Wisekey International Holding Ltd.
Announcement on the Nasdaq Tower in New York City can be viewed at https://youtu.be/28nV8L_TXaw?si=Fb1_EBN7LQcLGfFb Livestreams of the Expo’s conferences...
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 03, 2024 12:11 ET
|
Microbot Medical Inc.
HINGHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 1,566,669 shares of...
Crinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing’s Syndrome (ADCS)
June 03, 2024 12:00 ET
|
Crinetics Pharmaceuticals, Inc.
100% of Participants (n=6) With CAH Maintained Androstenedione (A4) Below the Upper Limit of Normal at all Time Points on Atumelnant (80 mg) CAH Participants Achieved More Than a 90% Reduction of...
Crinetics Presents New Data at ENDO 2024 that Increases Body of Evidence Positioning Once-Daily, Oral Paltusotine as Potential First-Choice Treatment Option for Acromegaly
June 03, 2024 12:00 ET
|
Crinetics Pharmaceuticals, Inc.
First Scientific Presentation of PATHFNDR-2 Acromegaly Safety and Efficacy Data Following Positive Topline Announcement, Showing Rapid and Sustained IGF-1 Responses in People Treated with Paltusotine ...
MidWestOne Financial Group Welcomes Three Key Executive Leaders to the Organization
June 03, 2024 11:00 ET
|
MidWestOne Bank
IOWA CITY, Iowa, June 03, 2024 (GLOBE NEWSWIRE) -- MidWestOne Financial Group, Inc. (NASDAQ: MOFG), parent company of MidWestOne Bank, a pre-eminent relationship-driven community bank, is pleased to...
Zevra Therapeutics Announces Positive Final Results from Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia at SLEEP 2024 Annual Meeting
June 03, 2024 11:00 ET
|
Zevra Therapeutics
KP1077 was well tolerated and showed meaningful clinical improvements in patient-reported assessments of daytime sleepiness, sleep inertia, and brain fog Additional data presented on...
Join Spectaire’s Exclusive Live Investor Webinar and Q&A Session on June 3
June 03, 2024 10:27 ET
|
Spectaire Holdings Inc.
WATERTOWN, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Spectaire Holdings Inc. (Nasdaq: SPEC) (“Spectaire” or the "Company,"), a pioneer in environmental measurement technology, is pleased to invite...
Trust Stamp CEO to Present at “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference, Presented by Maxim Group LLC on Tuesday, June 4th & Wednesday, June 5th, at 8:00 a.m. ET
June 03, 2024 10:00 ET
|
Trust Stamp
Atlanta, GA, June 03, 2024 (GLOBE NEWSWIRE) -- T Stamp Inc., Nasdaq: IDAI, the global identity company that develops AI-Powered, privacy first identity software used across numerous government and...